285 related articles for article (PubMed ID: 18290729)
41. Vitamin D and cellular Ca2+ signaling in breast cancer.
Sergeev IN
Anticancer Res; 2012 Jan; 32(1):299-302. PubMed ID: 22213319
[TBL] [Abstract][Full Text] [Related]
42. Molecular mechanisms of vitamin D action.
Haussler MR; Whitfield GK; Kaneko I; Haussler CA; Hsieh D; Hsieh JC; Jurutka PW
Calcif Tissue Int; 2013 Feb; 92(2):77-98. PubMed ID: 22782502
[TBL] [Abstract][Full Text] [Related]
43. Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer.
Welsh J; Wietzke JA; Zinser GM; Smyczek S; Romu S; Tribble E; Welsh JC; Byrne B; Narvaez CJ
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):85-92. PubMed ID: 12650704
[TBL] [Abstract][Full Text] [Related]
44. VDR in salivary gland homeostasis and cancer.
DeSantis KA; Robilotto SL; Matson M; Kotb NM; Lapierre CM; Minhas Z; Leder AA; Abdul K; Facteau EM; Welsh J
J Steroid Biochem Mol Biol; 2020 May; 199():105600. PubMed ID: 31958633
[TBL] [Abstract][Full Text] [Related]
45. A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified Vitamin D sterols.
Mizwicki MT; Bula CM; Bishop JE; Norman AW
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):69-82. PubMed ID: 16055325
[TBL] [Abstract][Full Text] [Related]
46. Vitamin D and breast cancer risk.
Colston KW
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):587-99. PubMed ID: 18971120
[TBL] [Abstract][Full Text] [Related]
47. Vitamin D and its role in skeletal muscle.
Ceglia L; Harris SS
Calcif Tissue Int; 2013 Feb; 92(2):151-62. PubMed ID: 22968766
[TBL] [Abstract][Full Text] [Related]
48. Correlation of prostaglandin metabolizing enzymes and serum PGE2 levels with vitamin D receptor and serum 25(OH)2D3 levels in breast and ovarian cancer.
Cordes T; Hoellen F; Dittmer C; Salehin D; Kümmel S; Friedrich M; Köster F; Becker S; Diedrich K; Thill M
Anticancer Res; 2012 Jan; 32(1):351-7. PubMed ID: 22213326
[TBL] [Abstract][Full Text] [Related]
49. Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells.
Alimirah F; Peng X; Gupta A; Yuan L; Welsh J; Cleary M; Mehta RG
Exp Cell Res; 2016 Nov; 349(1):15-22. PubMed ID: 27693451
[TBL] [Abstract][Full Text] [Related]
50. Vitamin D and breast cancer: Past and present.
Welsh J
J Steroid Biochem Mol Biol; 2018 Mar; 177():15-20. PubMed ID: 28746837
[TBL] [Abstract][Full Text] [Related]
51. Vitamin D, Pit-1, GH, and PRL: possible roles in breast cancer development.
Perez-Fernandez R; Seoane S; Garcia-Caballero T; Segura C; Macia M
Curr Med Chem; 2007; 14(29):3051-8. PubMed ID: 18220741
[TBL] [Abstract][Full Text] [Related]
52. Cellular and molecular effects of vitamin D on carcinogenesis.
Welsh J
Arch Biochem Biophys; 2012 Jul; 523(1):107-14. PubMed ID: 22085499
[TBL] [Abstract][Full Text] [Related]
53. Adipose-specific Vdr deletion alters body fat and enhances mammary epithelial density.
Matthews DG; D'Angelo J; Drelich J; Welsh J
J Steroid Biochem Mol Biol; 2016 Nov; 164():299-308. PubMed ID: 26429395
[TBL] [Abstract][Full Text] [Related]
54. Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues.
Zinser GM; Suckow M; Welsh J
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):153-64. PubMed ID: 16111884
[TBL] [Abstract][Full Text] [Related]
55. Vitamin D and breast cancer: insights from animal models.
Welsh J
Am J Clin Nutr; 2004 Dec; 80(6 Suppl):1721S-4S. PubMed ID: 15585794
[TBL] [Abstract][Full Text] [Related]
56. Vitamin D(3) receptor ablation alters mammary gland morphogenesis.
Zinser G; Packman K; Welsh J
Development; 2002 Jul; 129(13):3067-76. PubMed ID: 12070083
[TBL] [Abstract][Full Text] [Related]
57. IL-6 Impairs the Activity of Vitamin D3 in the Regulation of Epithelial-Mesenchymal Transition in Triple Negative Breast Cancer.
Abdel-Mohsen MA; Abo Deif SM; Abou-Shamaa LA
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2267-2273. PubMed ID: 31450894
[TBL] [Abstract][Full Text] [Related]
58. Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling.
Marshall PA; Hernandez Z; Kaneko I; Widener T; Tabacaru C; Aguayo I; Jurutka PW
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):147-59. PubMed ID: 22626544
[TBL] [Abstract][Full Text] [Related]
59. Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor.
Garay E; Donnelly R; Wang X; Studzinski GP
J Cell Physiol; 2007 Dec; 213(3):816-25. PubMed ID: 17520689
[TBL] [Abstract][Full Text] [Related]
60. Synthetically accessible non-secosteroidal hybrid molecules combining vitamin D receptor agonism and histone deacetylase inhibition.
Fischer J; Wang TT; Kaldre D; Rochel N; Moras D; White JH; Gleason JL
Chem Biol; 2012 Aug; 19(8):963-71. PubMed ID: 22921063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
